This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
FDA Drug information

Micafungin

Read time: 1 mins
Marketing start date: 23 Dec 2024
...
 

Summary of product characteristics


Effective Time

20221123

Version

1

Spl Product Data Elements

Micafungin Micafungin MICAFUNGIN SODIUM MICAFUNGIN LACTOSE MONOHYDRATE ANHYDROUS CITRIC ACID SODIUM HYDROXIDE Micafungin Micafungin MICAFUNGIN SODIUM MICAFUNGIN LACTOSE MONOHYDRATE ANHYDROUS CITRIC ACID SODIUM HYDROXIDE

Application Number

ANDA215241

Brand Name

Micafungin

Generic Name

Micafungin

Product Ndc

70771-1683

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL NDC 70771-1683-6 Micafungin for Injection 50 mg/vial For Intravenous Infusion Only 10 x 50 mg Single-Dose Vials Rx only NDC 70771-1684-6 Micafungin for Injection 100 mg/vial For Intravenous Infusion Only 10 x 100 mg Single-Dose Vials Rx only 50 mg per vial carton 100 mg per vial carton

Drug section

CME banner

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Click here to view

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.